LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX)

CUSIP: 528872302

Q2 2025 13F Holders as of 30 Jun 2025

Type / Class
Equity / Common Stock, par value $0.001 per share
Shares outstanding
444,558,533
Total 13F shares
256,310,843
Share change
-9,388,843
Total reported value
$242,983,204
Put/Call ratio
32%
Price per share
$0.95
Number of holders
121
Value change
-$6,845,383
Number of buys
59
Number of sells
67

Security key

528872302

Report period

Q2 2025

Institutions

121

Top holders

10

Top shareholders of LXRX - LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13D/G 13F
Company
10%
38,137,535
$26,696,274 +$2,516,037 30 Jun 2025
Artal Group S.A.
13F
Company
31%
136,180,481
$62,643,021 31 Mar 2025
13F
Siren, L.L.C.
3/4/5 13F
Director, 10%+ Owner · Individual
8.8%
from 13F
35,402,689
$92,755,045 25 Jul 2024
BlackRock, Inc.
13F
Company
2.3%
10,013,007
$4,613,995 31 Mar 2025
13F
VANGUARD GROUP INC
13F
Company
2.1%
9,557,175
$4,405,858 31 Mar 2025
13F
Schonfeld Strategic Advisors LLC
13F
Company
1.8%
8,212,993
$3,784,546 31 Mar 2025
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.83%
3,689,271
$1,700,415 31 Mar 2025
13F
STATE STREET CORP
13F
Company
0.59%
2,607,574
$1,201,570 31 Mar 2025
13F
CIBC Private Wealth Group LLC
13F
Company
0.5%
2,240,000
$1,122,464 31 Mar 2025
13F
UBS Group AG
13F
Company
0.47%
2,095,340
$965,951 31 Mar 2025
13F
Ikarian Capital, LLC
13F
Company
0.32%
1,417,952
$653,393 31 Mar 2025
13F
AQR CAPITAL MANAGEMENT LLC
13F
Company
0.26%
1,173,225
$540,622 31 Mar 2025
13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC
13F
Company
0.26%
1,150,771
$530,275 31 Mar 2025
13F
TANG CAPITAL MANAGEMENT LLC
13F
Company
0.26%
1,150,268
$530,043 31 Mar 2025
13F
NORTHERN TRUST CORP
13F
Company
0.25%
1,109,887
$511,435 31 Mar 2025
13F
SUSQUEHANNA INTERNATIONAL GROUP, LLP
13F
Company
0.21%
951,135
$438,283 31 Mar 2025
13F
Hennion & Walsh Asset Management, Inc.
13F
Company
0.19%
830,054
$382,489 31 Mar 2025
13F
GSA CAPITAL PARTNERS LLP
13F
Company
0.18%
807,492
$372,000 31 Mar 2025
13F
Monaco Asset Management SAM
13F
Company
0.17%
734,148
$338,295 31 Mar 2025
13F
MORGAN STANLEY
13F
Company
0.14%
641,629
$295,662 31 Mar 2025
13F
ACADIAN ASSET MANAGEMENT LLC
13F
Company
0.13%
573,688
$263,000 31 Mar 2025
13F
BBR PARTNERS, LLC
13F
Company
0.13%
570,000
$262,656 31 Mar 2025
13F
Nantahala Capital Management, LLC
13F
Company
0.1%
460,850
$212,360 31 Mar 2025
13F
BOOTHBAY FUND MANAGEMENT, LLC
13F
Company
0.1%
454,891
$209,614 31 Mar 2025
13F
Virtus Investment Advisers, LLC
13F
Company
0.1%
436,672
$201,218 31 Mar 2025
13F
GROUP ONE TRADING LLC
13F
Company
0.08%
365,806
$168,563 31 Mar 2025
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.08%
355,152
$163,654 31 Mar 2025
13F
Bank of New York Mellon Corp
13F
Company
0.07%
310,119
$142,902 31 Mar 2025
13F
Invesco Ltd.
13F
Company
0.06%
285,759
$131,678 31 Mar 2025
13F
ALLIANCEBERNSTEIN L.P.
13F
Company
0.06%
246,121
$113,413 31 Mar 2025
13F
Squarepoint Ops LLC
13F
Company
0.04%
195,409
$90,044 31 Mar 2025
13F
IEQ CAPITAL, LLC
13F
Company
0.04%
177,302
$81,701 31 Mar 2025
13F
SIMPLEX TRADING, LLC
13F
Company
0.04%
174,982
$80,000 31 Mar 2025
13F
Point72 Asia (Singapore) Pte. Ltd.
13F
Company
0.04%
171,147
$78,865 31 Mar 2025
13F
Cerity Partners LLC
13F
Company
0.04%
170,387
$78,514 31 Mar 2025
13F
BARCLAYS PLC
13F
Company
0.03%
146,071
$67,309 31 Mar 2025
13F
RHUMBLINE ADVISERS
13F
Company
0.03%
137,230
$63,252 31 Mar 2025
13F
Lombard Odier SCmA Compagnie
13F
Individual
0.02%
110,000
$50,688 31 Mar 2025
13F
CWM, LLC
13F
Company
0.02%
105,504
$49,000 31 Mar 2025
13F
BANK OF MONTREAL /CAN/
13F
Company
0.02%
100,000
$46,080 31 Mar 2025
13F
CITIGROUP INC
13F
Company
0.02%
96,968
$44,683 31 Mar 2025
13F
BANK OF AMERICA CORP /DE/
13F
Company
0.02%
96,387
$44,338 31 Mar 2025
13F
DEUTSCHE BANK AG\
13F
Company
0.02%
94,394
$43,421 31 Mar 2025
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
0.02%
92,248
$43,000 31 Mar 2025
13F
COMMONWEALTH EQUITY SERVICES, LLC
13F
Company
0.02%
90,864
$42,000 31 Mar 2025
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.02%
89,114
$41,064 31 Mar 2025
13F
JPMORGAN CHASE & CO
13F
Company
0.02%
88,199
$40,642 31 Mar 2025
13F
INTECH INVESTMENT MANAGEMENT LLC
13F
Company
0.02%
73,853
$34,031 31 Mar 2025
13F
China Universal Asset Management Co., Ltd.
13F
Company
0.02%
72,509
$33,412 31 Mar 2025
13F
LPL Financial LLC
13F
Company
0.02%
70,957
$32,697 31 Mar 2025
13F

Institutional Holders of LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) as of Q2 2025

As of 30 Jun 2025, LEXICON PHARMACEUTICALS, INC. - Common Stock, par value $0.001 per share (LXRX) was held by 121 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 256,310,843 shares. The largest 10 holders included Artal Group S.A., Siren, L.L.C., FMR LLC, VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, BlackRock, Inc., Sessa Capital IM, L.P., GSA CAPITAL PARTNERS LLP, CIBC Private Wealth Group LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 121 institutional shareholders reporting positions in this security for the Q2 2025 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q2 2025 vs Q1 2025 Across Filers

Q1 2025 holders
124
Q2 2025 holders
121
Holder diff
-3
Investor Q1 2025 Shares Q2 2025 Shares Share Diff Share Chg % Q1 2025 Value $ Q2 2025 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .